Format

Send to

Choose Destination
An Pediatr (Barc). 2016 Nov;85(5):256-265. doi: 10.1016/j.anpedi.2015.10.004. Epub 2015 Nov 19.

[Spanish consensus on infantile haemangioma].

[Article in Spanish]

Author information

1
Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, España. Electronic address: ebaselga@dermik.es.
2
Servicio de Dermatología, Hospital Universitario Virgen del Rocío, Sevilla, España.
3
Pediatría, CAP Pare Claret, Barcelona, España.
4
Servicio de Dermatología, Consorcio Hospital General Universitario de Valencia, València, España.
5
Pediatría, Centro de Salud Potosí, Madrid, España.
6
Servicio de Dermatología, Hospital Universitario La Paz, Madrid, España.
7
Servicio de Dermatología, Complejo Hospitalario Universitario A Coruña, A Coruña, España.
8
Servicio de Dermatología, Hospital Infantil Universitario Niño Jesús, Madrid, España.
9
Servicio de Cardiología Pediátrica, Hospital Universitario Miguel Servet, Zaragoza, España.
10
Servicio de Cirugía Pediátrica Hospital Universitario La Paz, Madrid, España.
11
Servicio de Dermatología, Hospital Universitario Son Espases, Palma de Mallorca, Islas Baleares, España.
12
Servicio de Dermatología, Clínica Universidad de Navarra, Pamplona, Navarra, España.
13
Pediatría, Centro de Salud Virgen de África, Sevilla, España.
14
Servicio de Dermatología, Hospital Regional Universitario Carlos Haya, Málaga, España.
15
Servicio de Dermatología, Hospital Sant Joan de Deu, Barcelona, Universidad de Barcelona, Esplugues de Llobregat, Barcelona, España.

Abstract

INTRODUCTION:

Infantile haemangiomas are benign tumours produced by the proliferation of endothelial cells of blood vessels, with a high incidence in children under the age of one year (4-10%). It is estimated that 12% of them require treatment. This treatment must be administered according to clinical practice guidelines, expert experience, patient characteristics and parent preferences.

METHODS:

The consensus process was performed by using scientific evidence on the diagnosis and treatment of infantile haemangiomas, culled from a systematic review of the literature, together with specialist expert opinions. The recommendations issued were validated by the specialists, who also provided their level of agreement.

RESULTS:

This document contains recommendations on the classification, associations, complications, diagnosis, treatment, and follow-up of patients with infantile haemangioma. It also includes action algorithms, and addresses multidisciplinary management and referral criteria between the different specialities involved in the clinical management of this type of patient.

CONCLUSIONS:

The recommendations and the diagnostic and therapeutic algorithms of infantile haemangiomas contained in this document are a useful tool for the proper management of these patients.

KEYWORDS:

Algorithms; Algoritmos; Haemangioma/classification; Haemangioma/complications; Haemangioma/diagnosis; Haemangioma/drug therapy; Hemangioma/clasificación; Hemangioma/complicaciones; Hemangioma/diagnóstico; Hemangioma/tratamiento; Infant; Niños; Propranolol

PMID:
26776166
DOI:
10.1016/j.anpedi.2015.10.004
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Ediciones Doyma, S.L.
Loading ...
Support Center